Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Extended Phenytoin Sodium Capsules USP, 100 mg.
The above information is a part of company’s filings submitted to BSE.